Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
HCI Group	HCI	13. nov 2024	112.39	-2.84
HCM II Acquisition	HONDU	13. nov 2024	10.04	0.00
HCM II Acquisition	HOND	13. nov 2024	10.01	0.00
HCW Biologics	HCWB	13. nov 2024	0.31	-1.87
HDFC Bank ADR	HDB	13. nov 2024	61.38	-1.22
Health Catalyst	HCAT	13. nov 2024	8.66	+6.52
Healthcare AI Acquisition A	HAIA	13. nov 2024	11.50	0.00
Healthcare Alphadex First Trust	FXH	13. nov 2024	111.08	-0.06
Healthcare Bull 3X Direxion	CURE	13. nov 2024	113.25	-0.84
Healthcare ETF Vanguard	VHT	13. nov 2024	271.29	-0.32
Healthcare Realty Trust	HR	13. nov 2024	17.58	+0.17
Healthcare Select Sector SPDR	XLV	13. nov 2024	146.83	-0.26
Healthcare Services Group	HCSG	13. nov 2024	12.19	-2.01
Healthcare Triangle	HCTI	13. nov 2024	1.22	-2.40
HealthEquity	HQY	13. nov 2024	94.80	-5.39
Healthpeak Properties	DOC	13. nov 2024	21.65	-0.64
HealthStream	HSTM	13. nov 2024	32.59	-0.03
Healthy Choice Wellness	HCWC	13. nov 2024	1.71	0.00
Heartbeam	BEAT	13. nov 2024	2.30	-2.54
Heartcore Enterprises	HTCR	13. nov 2024	1.25	+5.92
Heartland Express	HTLD	13. nov 2024	12.64	+0.56
Heartland Financial E Pref	HTLFP	13. nov 2024	25.25	+0.02
Heartland Financial USA	HTLF	13. nov 2024	66.42	-1.60
HeartSciences	HSCS	13. nov 2024	2.70	-4.26
Hecla Mining	HL	13. nov 2024	5.42	-0.73
Hecla Mining B Pref	HL-B	13. nov 2024	56.00	0.00
Hedge Replication ETF Proshares	HDG	13. nov 2024	50.18	-0.17
Heico	HEI	13. nov 2024	273.92	+3.95
Heico A	HEI-A	13. nov 2024	212.35	+3.46
Heidrick & Struggles International	HSII	13. nov 2024	47.16	-0.27

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.